Shanghai Rendu Biotechnology Co. Ltd. A (688193) - Total Liabilities

Latest as of March 2026: CN¥65.45 Million CNY ≈ $9.58 Million USD

Based on the latest financial reports, Shanghai Rendu Biotechnology Co. Ltd. A (688193) has total liabilities worth CN¥65.45 Million CNY (≈ $9.58 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Shanghai Rendu Biotechnology Co. Ltd. A to assess how effectively this company generates cash.

Shanghai Rendu Biotechnology Co. Ltd. A - Total Liabilities Trend (2019–2025)

This chart illustrates how Shanghai Rendu Biotechnology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Shanghai Rendu Biotechnology Co. Ltd. A's assets to evaluate the company's liquid asset resilience ratio.

Shanghai Rendu Biotechnology Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shanghai Rendu Biotechnology Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Shanghai Mechanical & Electrical Industry Co Ltd B SHG:900925	China	$15.81 Billion
DB INC KO:012030	Korea	₩464.00 Billion
Baiyang Aquatic Group Inc SHE:002696	China	CN¥2.19 Billion
Perpetual Credit Income Trust AU:PCI	Australia	AU$4.44 Million
CyberTAN Technology Inc TW:3062	Taiwan	NT$2.05 Billion
BMTC Group Inc TO:GBT	Canada	CA$169.25 Million
Repay Holdings Corp NASDAQ:RPAY	USA	$665.54 Million
M3-Brigade Acquisition V Corp. Class A Ordinary shares NASDAQ:MBAV	USA	$19.58 Million

Liability Composition Analysis (2019–2025)

This chart breaks down Shanghai Rendu Biotechnology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Shanghai Rendu Biotechnology Co. Ltd. A worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	14.97	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Rendu Biotechnology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)

The table below shows the annual total liabilities of Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥76.26 Million ≈ $11.16 Million	-7.54%
2024-12-31	CN¥82.48 Million ≈ $12.07 Million	-10.32%
2023-12-31	CN¥91.97 Million ≈ $13.46 Million	-27.77%
2022-12-31	CN¥127.34 Million ≈ $18.63 Million	+40.15%
2021-12-31	CN¥90.86 Million ≈ $13.30 Million	-5.11%
2020-12-31	CN¥95.75 Million ≈ $14.01 Million	+163.00%
2019-12-31	CN¥36.41 Million ≈ $5.33 Million	--

About Shanghai Rendu Biotechnology Co. Ltd. A

SHG:688193 China Diagnostics & Research

Market Cap

$310.65 Million

CN¥2.12 Billion CNY

Market Cap Rank

#14888 Global

#4536 in China

Share Price

CN¥52.98

Change (1 day)

-2.47%

52-Week Range

CN¥38.09 - CN¥61.67

All Time High

CN¥63.91